Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.84 USD | +4.46% | +3.88% | -28.57% |
05-29 | Transcript : BridgeBio Pharma, Inc. - Special Call | |
05-28 | UBS Adjusts Price Target on BridgeBio Pharma to $47 From $51, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.57% | 5.4B | |
-2.29% | 89.38B | |
-3.68% | 37.92B | |
-14.91% | 32.04B | |
+61.41% | 26.03B | |
-22.72% | 14.14B | |
-8.73% | 12.88B | |
-10.57% | 11.77B | |
+3.82% | 8.92B | |
-17.66% | 7.34B |
- Stock Market
- Equities
- BBIO Stock
- News BridgeBio Pharma, Inc.
- Transcript : BridgeBio Pharma, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 03